TrialJournal of clinical pharmacology2026

Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.

Atul Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.